GSA Capital Partners’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.37M | Buy |
279,418
+190,507
| +214% | +$1.61M | 0.17% | 85 |
|
|
2025
Q1 | $715K | Buy |
88,911
+77,153
| +656% | +$620K | 0.06% | 553 |
|
|
2024
Q4 | $106K | Sell |
11,758
-113,887
| -91% | -$1.03M | 0.01% | 1507 |
|
|
2024
Q3 | $921K | Sell |
125,645
-102,373
| -45% | -$750K | 0.07% | 522 |
|
|
2024
Q2 | $1.3M | Sell |
228,018
-121,186
| -35% | -$692K | 0.09% | 342 |
|
|
2024
Q1 | $1.75M | Buy |
349,204
+231,260
| +196% | +$1.16M | 0.14% | 158 |
|
|
2023
Q4 | $1.06M | Buy |
+117,944
| New | +$1.06M | 0.09% | 360 |
|
|
2023
Q3 | – | Sell |
-168,595
| Closed | -$1.63M | – | 1488 |
|
|
2023
Q2 | $1.63M | Buy |
+168,595
| New | +$1.63M | 0.16% | 113 |
|
|
2021
Q4 | – | Sell |
-22,904
| Closed | -$507K | – | 1404 |
|
|
2021
Q3 | $507K | Buy |
+22,904
| New | +$507K | 0.05% | 687 |
|